Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Felmlee

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|April 2, 2022
Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosisDavid A Sheridan, Isaac Thom Shawa, E Louise Thomas, et al.
Journal of Hepatology|March 15, 2012
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivityDavid A Sheridan, Simon H Bridge, Daniel J Felmlee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trialDavid A Sheridan, Simon H Bridge, Mary M E Crossey, et al.
Gastroenterology|August 5, 2010
Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particlesDaniel J Felmlee, David A Sheridan, Simon H Bridge, et al.
Journal of Hepatology|December 3, 2014
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolismSimon H Bridge, David A Sheridan, Daniel J Felmlee, et al.
Gastroenterology|September 26, 2015
Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing AntibodiesCatherine Fauvelle, Daniel J Felmlee, Emilie Crouchet, et al.
Hepatology (Baltimore, Md.)|July 31, 2015
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|April 2, 2022
Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosisDavid A Sheridan, Isaac Thom Shawa, E Louise Thomas, et al.
Journal of Hepatology|March 15, 2012
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivityDavid A Sheridan, Simon H Bridge, Daniel J Felmlee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trialDavid A Sheridan, Simon H Bridge, Mary M E Crossey, et al.
Gastroenterology|August 5, 2010
Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particlesDaniel J Felmlee, David A Sheridan, Simon H Bridge, et al.
Journal of Hepatology|December 3, 2014
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolismSimon H Bridge, David A Sheridan, Daniel J Felmlee, et al.
Gastroenterology|September 26, 2015
Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing AntibodiesCatherine Fauvelle, Daniel J Felmlee, Emilie Crouchet, et al.
Hepatology (Baltimore, Md.)|July 31, 2015
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D virusesEloi R Verrier, Che C Colpitts, Charlotte Bach, et al.
Pageof 3